Synbiotic Health develops new probiotic strains for humans and companion animals, discovered through the use of their proprietary IVS and IVE platforms, allowing for the isolation of new microbes based on selective and competitive conditions.
Studies
A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults.
Davis et al, 2010
Barcoded Pyrosequencing Reveals That Consumption of Galactooligosaccharides Results in a Highly Specific Bifidogenic Response in Humans.
Davis et al, 2011
In Vivo Selection To Identify Bacterial Strains with Enhanced Ecological Performance in Synbiotic Applications.
Krumbeck et al, 2015
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
Krumbeck et al, 2018